baber/WOPTO huggingface dataset:
Patent MX-7381-E (MX)
Inventor: AKESSON YNGVE REINHOLD
IPC: A22C11/00
Filed: 1982-08-20
Abstract: A process for the continuous production of an elongate rodshaped comminuted meat product which comprises feeding a flowable protein-containing food mixture into a hollow mould which travels through a microwave oven and which is formed by the co-operation of the adjacent runs of a pair of endless flexible belts which have a sealing system and afterwards releasing the meat product from the hollow mould characterised in that the sealing system comprises, on each side of the hollow mould, at least one longitudinal projection on one belt engaging with at least one corresponding recess on the other belt.
Patent PT-1099663-E (PT)
Inventor: TILL RUDOLF
IPC: B67D1/08
Filed: 2000-10-27
Abstract: The dispensing head includes a casing (1) containing a closing bolt (2), which has an up-and-down moving slide (4) round it, In the up position, at the barrel end, its flange seal (21) is against the lower part of the casing. In the down position, the ram (19) is sealed against the closing bolt by an O-ring (19a). The closing bolt may be connected to the casing by a fixing screw (3).
Patent PT-1072601-E (PT)
Inventor: TOMMASINI IVAN
IPC: A61K31/445
Filed: 2000-05-18
Abstract: There is provided a compound of formula I,  <CHEM>  wherein Het<1>, R<1>, R<2>, R<3>, X and n have meanings given in the description, which are useful in the prophylaxis and in the treatment of diseases mediated by opiate receptors, such as pruritus.
Patent PT-1118280-E (PT)
Inventor: TOMAT ANDREA
IPC: A43B7/08
Filed: 2000-11-30
Abstract: Sole structure able to associated to an upper (2) of a shoe (1), having first ducts (8) in the area (7) of the plantar arch and of the tip and one or more lateral openings (9) in the heel area (30). In the heel area (30) is obtained a seat (11) for a counter-shaped insert (12) provided with at least an elastically compressible central area (14), inferiorly communicating with second ducts (17) communicating in turn with third ducts (19) obtained superiorly to the insert (12) and communicating with the first ducts (8) and with the openings (9a), (9b) and (9c) through the interposition of a gasket (22) permeable to air but not to water. The insert (12) has an upper surface (13) whereon is obtained a central area (14), elastically compressible and inferiorly communicating with a cavity (15), obtained on a lower surface (16) of the insert (12), in such a way that to a deformation of the central area (14) corresponds a variation of the volume of the cavity (15). <IMAGE>
Patent PT-1165974-E (PT)
Inventor: ROBERT DICKE DIPL ING
IPC: F16B35/06
Filed: 2000-02-25
Abstract: The invention relates to a countersunk head screw having a head (1), a shank (2) and a thread (3) extending at least partly over the shank (2). The head (1) has a bearing surface (4), narrowing in the direction of the shank (2), and a basic contour (5) which converges at a first angle (alpha) in a first head section (5a) remote from the shank (2) and at a second, smaller angle (beta) in a second head section (5b) facing the shank (2). In order to avoid, for example, undesirable deformations, splintering, tearing or the like, provision is made for friction ribs (6) to be arranged in the region of the bearing surface (4), and these friction rigs (6) extend over the two head sections (5a, 5b) and, with their outer edges (K), follow the converging basic contour (5) of the head (1), so that in each case the first edge section (6a), lying in the region of the first head section (5a), and a second edge section (6b), lying in the region of the second head section (5b), of the outer edges (K) of the friction ribs (6) enclose an obtuse angle (gamma) with one another. The bearing surface (4) is set back radially in the direction of the shank (2) relative to the converging basic contour (5) of the head (1).
Patent PT-1200578-E (PT)
Inventor: BUTLER MICHELLE D
IPC: C12N15/09
Filed: 2000-07-21
Abstract: A process is described for purifying plasmid DNA from prokaryotic cells comprised thereof. This process comprises the steps of: (a) digesting the cells; (b) incubating the cells for about 4 to 24 hours to effect lysis and solubilization thereof, without effecting enzymatic digestion of RNA; (c) removing lysate contaminants from the cells to provide a plasmid DNA solution; (d) filtering the solution through a tangential flow filtration device to obtain a retentate containing the plasmid DNA; and (e) collecting the retentate.
Patent PT-1233118-E (PT)
Inventor: GIESENKAEMPER JAN DIPL ING
IPC: E04F13/08
Filed: 2002-02-08
Abstract: The facade cladding (1), for a building, has a support structure (2) secured to the building wall (3). The facade is fitted with inner rectangular cassettes (7) against the support structure, with folds (12) along their longitudinal sides (11) and cut-back profiles. Rectangular cladding cassettes (16) are clipped to the inner cassettes, with their longitudinal sides gripping around them in a force fit. Clamping bars are at the longitudinal sides (15) of the cladding cassettes, to fit into the cut-back profiles and lock the cladding in position.
Patent PT-1342852-E (PT)
Inventor: FH HUDELMAIER KLAUS DIPL-ING
IPC: E02D7/24
Filed: 2002-03-06
Abstract: The method is for supporting and sealing an earth area involves a spigot board (10) and a sieve device (14) installed in the ground until the lower end has penetrated a ground layer (18) with reduced water permeability. Then the spigot board is withdrawn, so that a slot (19) is formed in the earth area, in which a sealing concrete suspension is injected through a tube (12).  Finally, the spigot board is pressed back into the filled slot. On hardening, the concrete suspension forms a concrete surround at the lower end of the spigot board, which is connected in a sealed manner both with the surrounding earth and the spigot board.
Patent PT-1360287-E (PT)
Title: Methods of modifying eukaryotic cells
Inventor: YANCOPOULOS GEORGE D
IPC: C12Q1/68
Filed: 2002-02-15
Abstract: A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.
Patent PT-1483390-E (PT)
Title: Transgenic plants synthesising high amylose starch
Inventor: UWER URSULA
IPC: C12N9/10
Filed: 2002-06-07
Abstract: Transgenic plant cells and plants are described which synthesise a starch which is modified in comparison with corresponding wild type plant cells and plants. The plant cells and plants described show a reduced activity of R1, BEI and BEII proteins. Furthermore, modified starches as well as methods for their production are described.
Patent PT-1399111-E (PT)
Title: Sterile injectable composition for aesthetic and/or reparative uses
Inventor: BELLITY PHILIPPE
IPC: A61Q19/08
Filed: 2002-06-13
Abstract: The invention relates to a sterile injectable composition for aesthetic and/or reparative uses, characterised in comprising an effective amount of at least one colorant of an appropriate colour and a biocompatible vector to control the diffusion of said colorant on injecting said composition into the sub-cutaneous, sub-dermal, and/or intra-dermal layer precisely in the zone for treatment.
Patent PT-1418965-E (PT)
Inventor: FERNANCE KENDALL MARK ANTHONY
IPC: A61M5/30
Filed: 2002-07-25
Abstract: The invention provides a silencer and silencing method which ensures adequate silencing with no deleterious increase in back pressure (which creates a lift-off force) or decrease in device performance. Pressurised gas is supplied to a driver chamber by a bleed-hole having an effective bleed-hole area and, during use of the device for particle delivery, gas is vented to the atmosphere via a silencer having an effective venting area. The bleed-hole area and venting area are chosen to ensure that the mass flow rate of gas through the effective venting area is substantially equal to or greater than the mass flow rate of gas through the effective bleed-hole area. This ensures that there is no build up of gas in the silencer device which tends to increase back pressure and hence lift-off force. Preferred embodiments of the device comprise a silencer having a large volume and a small particle exit opening. Further, there is disclosed an embodiment using one or more transfer ducts to assist particle mixing.
Patent PT-1486572-E (PT)
Title: Apparatus for induction hardening
Inventor: ZAHN ANDREAS
IPC: C21D1/10
Filed: 2003-06-13
Abstract: An assembly hardens metal components of circular cross-section e.g. a crankshaft (2) by inductive heating. The induction heating assembly consists of two semi-circular shells (4, 5), both of which incorporate an electric current-flow detent (6).
Patent PT-1480634-E (PT)
Title: Selective androgen receptor modulators (sarms) for treating benign prostate hyperplasia
Inventor: STEINER MITCHELL S
IPC: A61K31/56
Filed: 2003-02-06
Abstract: This invention provides a method of treating, preventing, suppressing, inhibiting or reducing the incidence of benign prostate hyperplasia in a male subject, by administering to the subject a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof as described herein. This invention also provides a method of treating a subject suffering from hair loss, comprising the step of administering to the subject a therapeutically effective amount of a 5-α reductase enzyme type 1 and/or type 2 inhibitor, wherein said inhibitor is a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof as described herein. This invention also provides a method of inhibiting a 5-α reductase type 1 and/or type 2 enzyme, comprising contacting the enzyme with an effective 5-α reductase inhibitory amount of a selective androgen receptor modulator (SARM) and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof, as described herein.
Patent PT-1627530-E (PT)
Title: Method for recording an elapsed time period in a security module
Inventor: COCHARD JIMMY
IPC: H04N7/16
Filed: 2004-05-12
Abstract: Example embodiments are directed to a duration computing method in a security module inserted into an apparatus including an internal clock. The apparatus may receive a digital data stream encrypted via control words contained in a control message ECM. The method may include receiving data coming from the internal clock of the apparatus including a current temporal information, storing the data representing the current temporal information in the security module, receiving the control message ECM to decrypt at least one control word, reading previous data representing a previous temporal information at a moment of processing the previous control message ECM, and processing the control message ECM when the current temporal information is temporally ahead of the previous temporal information.
Patent PT-1775086-E (PT)
Title: Method of making brightly coloured fibre boards
Inventor: ALFRED PFEMETER DR
IPC: B27N1/00
Filed: 2006-10-13
Abstract: Production of wood fiber board comprises feeding bleached fiber (1) as starting material containing wood fibers to a refiner (4) outside of the production plant. Preferred Features: The fiber consists of fiber bundles mechanically abraded from solid wood and single wood fibers. The fiber is chemically bleached with an oxidant which is added to the wood fibers in the refiner. Dyes (2) are added to the wood fibers.
Patent PT-1965649-E (PT)
Title: Protection of plants against their pathogenic agents
Inventor: PUJOS PHILIPPE
IPC: A01N63/32
Filed: 2006-12-21
Abstract: Use of a composition comprising yeast to treat/protect plants against the diseases caused by pathogenic agents or induce/stimulate natural defenses of plant against pathogenic agents. - ACTIVITY : Plant Growth Regulant; Plant Growth Stimulant; Plant Protectant; Virucide. - MECHANISM OF ACTION : None given.
Patent PT-1867824-E (PT)
Title: A method for mounting an auxiliary member on the fitting of a door or window
Inventor: VINADIO AIMONE BALBO DI
IPC: E05D15/52
Filed: 2007-05-18
Abstract: Method for mounting an auxiliary member (130) on a window or door frame (10) already installed and whereon is mounted a drive assembly (22) comprising at least one actuating member (24, 25, 26, 27, 28) and at least one transmission rod (30, 32) mounted in at least one slot (18, 20) of the frame (10). The method comprises the steps of: 
- providing, between the auxiliary member (130) and said rod (30, 32), a coupling that is slidable in a longitudinal direction and fixed in any direction orthogonal to the direction of sliding, and 
- forming a through hole (118) in the rod by means of a screw (106) carried by the auxiliary member (130), and fastening the auxiliary member to said rod (30, 32) by the engagement of a tip (110) of said screw (106) with said through hole (118).
Patent PT-2094183-E (PT)
Title: Yankauer suction device with sleeve and wiper
Inventor: HERSHEY ADRIENNE A
IPC: A61C1/16
Filed: 2007-08-23
Abstract: A suction device includes an elongated suction tube having a suction tip at a distal end thereof, and a proximal end that is connectable to a suction source. A collar is slidable along the suction tube from a retracted position to a deployed position. A sleeve is provided having a proximal end fixed relative to the proximal end of the suction tube, and a distal end configured with the collar so as to move therewith and cover the suction tube in the deployed position of the collar. A wiper seal is contained within collar in sliding frictional engagement around the suction tube.
Patent PT-2275119-E (PT)
Title: Stable isotonic lyophilized protein formulation
Inventor: ANDYA JAMES
IPC: A61K38/00
Filed: 1996-07-23
Abstract: A stable lyophilized protein formulation is described which can be reconstituted with a suitable diluent to generate a high protein concentration reconstituted formulation which is suitable for subcutaneous administration. For example, anti-IgE and anti-HER2 antibody formulations have been prepared by lyophilizing these antibodies in the presence of a lyoprotectant. The lyophilized mixture thus formed is reconstituted to a high protein concentration without apparent loss of stability of the protein.
Patent PT-777838-E (PT)
Inventor: NECHVATAL TIMOTHY M
IPC: F23G5/08
Filed: 1995-08-17
Abstract: Paper mill sludge or similar organic sludges with a high ash content are converted by burning the sludge in a cyclone furnace along with another source of fuel. The heat content of the sludge is recovered and the ash content of the sludge is converted to a glassy slag. A flux, such as limestone, may be added to the sludge before introduction into the cyclone furnace. The slag is useful as a construction material, an abrasive, for roofing products, or for other purposes.
Patent PT-776301-E (PT)
Inventor: VANMOOR ARTHUR
IPC: B65D83/00
Filed: 1995-09-13
Abstract: A caulking gun and cartridge combination is provided with afterflow prevention. The cartridge has a tubular body (8), a forward dispensing opening (9) at a forward end of the tubular body, and a backwall (11, 12) movably disposed within the tubular body (8). The caulking gun has a trough (1) for receiving the cartridge, and a piston (4) movable parallel to the trough (1). A trigger handle (23) is used for pushing the backwall (11) forward within the tubular body and causing a reduction of volume within the chamber (13) in the cartridge. The backwall slides substantially in a contact-less manner within the tubular body, preferebly by way of a reduced diameter (OD) of the backwall (11) relative the inner diameter (ID) of the tubular body (8), so that it is pushed backwardly when the body retracts radially after actuation. Alternatively, the cartridge body may be prevented from expanding or may even be actively squeezed so that afterflow caused by the volume reduction of the relaxing tube body is safely prevented.
Patent PT-802257-E (PT)
Inventor: BLUM STEPHANIE
IPC: C12Q1/00
Filed: 1996-04-19
Abstract: Immortalised human colon epithelial cell line has no tumour markers, expresses metabolic markers specific for non-immortalised human epithelial cells, expresses differentiation markers specific for non-immortalised human colon epithelial cells, and is capable of adhering to lactic acid bacterium CNCM I-1225 in vitro. Also claimed are: (1) a serum-free culture medium for culturing and immortalising human colon epithelial cells, containing inorganic salts, glucose, sodium pyruvate, amino acids, bovine serum albumin, ethanolamine, phosphoethanolamine, vitamins (vitamin C and retinoic acid), trace elements and hormones (triiodothyronine, dexamethasone, hydrocortisone, bovine pituitary extract, insulin, epithelial growth factor and transferrin), and (2) a process for immortalising human colon epithelial cells, comprising preparing a primary culture of the cells, infecting the culture with a recombinant virus, and culturing the cells in a medium as above.
Patent PT-850215-E (PT)
Inventor: KLEINMAN EDWARD F
IPC: C07D205/04
Filed: 1996-05-14
Abstract: Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, AA and Y are as defined herein, inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor, and therefore are useful in the treatment of certain conditions and diseases including asthma, arthritis, and sepsis.
Patent PT-838380-E (PT)
Inventor: BENIMELI FERMIN JAIME LOUREIRO
IPC: G07G1/12
Filed: 1997-04-22
Abstract: Electronic air dispensing and pressure balancing system for tyres to be installed preferably in petrol stations, service areas, mechanical assistance stations on roads or the like, of the type comprising a compression unit which, either through a tank or directly, supplies a gas, preferably compressed air, to an inflation unit which has a plurality of inflation conduits provided at their free ends with means for coupling said inflation conduits to the tyre valve, as well as a supporting structure for said conduits, having an actuation unit or a machine (1) comprised of a case (2), a metal frame (11), an electronic mesuring instrument, a pneumatic equipment (35), a propulsor or compressor equipment, with an external or internal compression unit, a base or support unit and an air supplying unit (5). <IMAGE>
Patent PT-914129-E (PT)
Inventor: ISLAM KHALID
IPC: A61K31/55
Filed: 1997-04-23
Abstract: PCT No. PCT/EP97/02049 Sec. 371 Date Oct. 26, 1999 Sec. 102(e) Date Oct. 26, 1998 PCT Filed Apr. 23, 1997 PCT Pub. No. WO97/41862 PCT Pub. Date Nov. 13, 1997Use of a compound of formula (I) wherein R represents hydrogen or chlorine, for preparing an immunosuppressive medicament.
Patent PT-1156858-E (PT)
Title: Skateboard
Inventor: COLON BECKET
IPC: A63C17/02
Filed: 1999-11-15
Abstract: A kicktail concave skateboard includes a blank having opposite ends, at least one end being recessed. An element is mounted on the recessed end such that a portion of the element adjoining the blank is flush with the blank. The element is formed of a material having a lower mechanical damping capacity and a higher modulus of elasticity than the blank. The element includes a downwardly facing exposed side having a downward projection thereon, to facilitate the execution of an “ollie” maneuver.
Patent PT-1140149-E (PT)
Title: Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment
Inventor: GIANNI ALESSANDRO MASSIMO
IPC: A61K35/28
Filed: 1999-12-30
Abstract: The invention relates to the field of hematopoietic CD34 +  cell mobilization. In particular, this invention relates to a method for increasing the mobilization of pluripotent hematopoietic CD34 +  cells by administration of human growth hormone or one of its derivates to the individual.
Patent IE-800298-L (IE)
Title: Laying a foam-backed covering on a support
IPC: E04F15/16
Filed: 1980-02-18
Abstract: The method comprises the laying of an intermediate layer (2) with meshing directly on to the surface of the support (1), the gluing of the upper face of the intermediate layer so as to permit the passage of the adhesive material (5) through the meshing of the intermediate layer to the support, and the application of the covering material (6) with foam backing (7) on to the adhesive layer. <IMAGE>
[EP0015039A1]
Patent IE-35027-L (IE)
Title: Aryloxy-and alkylthio-alkanoic acids.
IPC: C07D333/76
Filed: 1971-03-19
Abstract: 1331839 Aryloxy and aryl thioalkanoic acids, amides and esters CIBA-GEIGY AG 19 April 1971 [20 March 1970] 24671/71 Heading C2C Novel aryloxy- and arylthioalkanoic acids, amides and esters of the Formula I wherein R 1 is a C 1-14 alkyl or C 5-7 cycloalkyl; R 2 is hydrogen or methyl; R 3 is OH, OM, C 1-3 alkoxy or unsubstituted amino; X and Y are independently oxygen or sulphur and M is an alkali or alkaline earth metal may be prepared by (a) condensing an alkali metal salt of II with a compound III wherein A is halogen, alkylsulphonyloxy or arylsulphonyloxy; (b) forming the free acid I by hydrolysing a functional derivative of I to form a carboxyl group at COR 3 ; (c) forming I in which R 2 is hydrogen and R 3 hydroxy by heating under hydrolysing conditions a compound IV wherein Z 1 and Z 2 are independently C 1-6 alkoxycarbonyl or nitrile, until one Z group is hydrolysed and the other is replaced by hydrogen; (d) I in which R 2 is hydrogen, heating to remove a mole of carbon dioxide from V (e), for I in which R 3 is NH 2 , reacting a compound VI wherein B is halogen or alkoxy, with ammonia; (f), for I in which R 3 is NH 2 , partially hydrolysing a nitrile group of VII to CONH 2 ; (g), for I in which R 3 is a C 1-3 alkoxy, reacting VII with a C 1-3 alkanol in the presence of water and mineral acid; (h) forming an alkali metal derivative of an alkali metal salt or a halomagnesium derivative of a halo-magnesium salt of acid VIII and reacting the organo metallic compound with a mole of R 1 A wherein A is as above; (i), for I in which R 2 is methyl and R 3 is hydroxy, reacting a compound II with a methane tri- or tetra-substituted by chlorine and/or bromine and a ketone R 1 COCH 3 or the reaction product of the latter two compounds, i.e. XI wherein Hal is chlorine or bromine, in the presence of at least a fourfold excess molar amount of a strong base and; (j) optionally converting free acids to salts with alkali- or alkaline earth metals and vice versa. The intermediates II may be formed by reacting a sodium m- or p-methoxy phenolate or thiophenolate with 2-bromo cyclohexanone to form the 2(m or p-methoxy phenoxy or phenylthiol)-cyclohexanone cyclizing the product with ortho-phosphoric acid to give 2 or 3 methoxy - 6,7,8,9 - tetrahydrodibenzo - furan or thiophene, followed by demethylation with pyridine hydrochloride. The compound II in which X is oxygen may be converted to those in which X is sulphur by forming the dimethyl thiocarbamic acid ester at the 2- or 3-position of the ring, rearranging the ester to a dimethyl carbamic acid 5-ester and hydrolysing to give II in which X is sulphur. The intermediates IV, V, VII and VIII may be prepared by processes similar to (a) above. Pharmaceutical compositions of the compounds I show hypolipaemic activity when administered orally or parenterally with the usual excipients.
[GB1331839A]